Making the business case for enhanced depression care: The National Institute of Mental Health-Harvard Work Outcomes Research and Cost-Effectiveness Study

被引:32
|
作者
Wang, Philip S. [1 ,2 ,3 ]
Simon, Gregory E. [4 ]
Kessler, Ronald C. [3 ]
机构
[1] NIMH, Div Serv & Intervent Res, Rockville, MD 20857 USA
[2] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
关键词
D O I
10.1097/JOM.0b013e31816a8931
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Explore the business case for enhanced depression care and establish a return on investment rationale for increased organizational involvement by employer-purchasers. Method. Literature review, focused on the National Institute of Mental Health-sponsored Work Outcomes Research and Cost-effectiveness Study. Results: This randomized controlled trial compared telephone outreach, care management, and optional psychotherapy to usual care among depressed workers in large national corporations. By 12 months, the intervention significantly improved depression outcomes, work retention, and hours worked among the employed Conclusion: Results of the Work Outcomes Research and Cost-effectiveness Study trial and other studies suggest that enhanced depression care programs represent a human capital investment opportunity for employers.
引用
收藏
页码:468 / 475
页数:8
相关论文
共 50 条
  • [1] Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
    Claxton, Karl
    Martin, Steve
    Soares, Marta
    Rice, Nigel
    Spackman, Eldon
    Hinde, Sebastian
    Devlin, Nancy
    Smith, Peter C.
    Sculpher, Mark
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (14) : 1 - +
  • [2] Case study in the Bayesian analysis of a cost-effectiveness trial in the evaluation of health care technologies: Depression
    Stevens, JW
    O'Hagan, A
    Miller, P
    [J]. PHARMACEUTICAL STATISTICS, 2003, 2 (01) : 51 - 68
  • [3] The cost-effectiveness of public health interventions examined by the National Institute for Health and Care Excellence from 2005 to 2018
    Owen, L.
    Fischer, A.
    [J]. PUBLIC HEALTH, 2019, 169 : 151 - 162
  • [4] A Cost-effectiveness Study of the Impact of the Affordable Care Act on Depression Outcomes in the United States
    Mohit, Babak
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2018, 21 (02): : 71 - 78
  • [5] NATIONAL-INSTITUTE-OF-MENTAL-HEALTH TREATMENT OF DEPRESSION COLLABORATIVE RESEARCH-PROGRAM - GENERAL EFFECTIVENESS OF TREATMENTS
    ELKIN, I
    SHEA, MT
    WATKINS, JT
    IMBER, SD
    SOTSKY, SM
    COLLINS, JF
    GLASS, DR
    PILKONIS, PA
    LEBER, WR
    DOCHERTY, JP
    FIESTER, SJ
    PARLOFF, MB
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1989, 46 (11) : 971 - 982
  • [6] Making research everybody's business: a position statement of the Royal College of Physicians and the National Institute of Health and Care Research
    Arasaradnam, Ramesh
    Clarke, Sarah
    van't Hoff, William
    Chappell, Lucy
    [J]. CLINICAL MEDICINE, 2023, 23 (02): : 102 - 105
  • [7] DIFFERENT VALUES IN COST-EFFECTIVENESS RESEARCH: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) VS. THE NATIONAL INSTITUTE FOR CARE EXCELLENCE (NICE)
    Liden, D.
    Jaksa, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A501 - A501
  • [8] USE OF PATIENT-REPORTED OUTCOMES AS KEY DRIVERS IN COST-EFFECTIVENESS MODELS: A REVIEW OF UK NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE HEALTH TECHNOLOGY ASSESSMENTS
    Dong, O.
    Manga, N.
    Zhong, Y.
    Zhang, Y.
    Krause, T.
    Griffin, J.
    Herring, W.
    Wolowacz, S.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S78 - S78
  • [9] Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicines
    Gallacher, Daniel
    Stallard, Nigel
    Kimani, Peter
    Gokalp, Elvan
    Branke, Juergen
    [J]. HEALTH ECONOMICS, 2022, 31 (02) : 417 - 430
  • [10] REANALYSIS OF THE NATIONAL INSTITUTE OF MENTAL-HEALTH TREATMENT OF DEPRESSION COLLABORATIVE RESEARCH-PROGRAM GENERAL EFFECTIVENESS REPORT
    KLEIN, DF
    ROSS, DC
    [J]. NEUROPSYCHOPHARMACOLOGY, 1993, 8 (03) : 241 - 251